Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Dollar General Corporation (DG)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 26, 2024 deadline to file a lead plaintiff... Read more.
bluebird bio Announces FDA Approval of LYFGENIA™ (lovotibeglogene autotemcel) for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Severe vaso-occlusive events were eliminated for 94% (30/32) of evaluable patients and all VOEs were eliminated for 88% (28/32) of evaluable patients between 6 and... Read more.
SiMa.ai Honored by the Global Semiconductor Association with 2023 Startup to Watch Award
Edge ML leader selected for its differentiated, software-driven Machine Learning System on Chip (MLSoC) platform SAN JOSE, Calif.–(BUSINESS WIRE)–SiMa.ai,... Read more.
Global Meal Kit Delivery Report 2023: A $33.7 Bn Industry by 2029 Featuring HelloFresh, Blue Apron, Marley Spoon, Gobble, Daily Harvest, Sunbasket, Fresh N Lean, Home Chef, Hungryroot, & Purple Carrot – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Meal Kit Delivery Market (2023 Edition): Analysis By Offering Type (Heat and Eat, Cook and Eat), Sales Channel... Read more.
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of LivePerson, Inc. (LPSN) Investors
NEW YORK–(BUSINESS WIRE)–$LPSN #classactionlawsuit–The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in... Read more.
SmartMetric Says That, According to the Federal Reserve, Credit Cards Dominate the Payment Method Used by Consumers
NEW YORK–(BUSINESS WIRE)–#americanexpress–SmartMetric, Inc. (OTC: SMME): According to a recently released report titled the 2023 Diary of Consumer... Read more.
Phillips 66 Announces 2024 Capital Program
Disciplined Capital Allocation to Advance Strategic Priorities HOUSTON–(BUSINESS WIRE)–Phillips 66 (NYSE: PSX) today announced a 2024 capital budget... Read more.
Hampton Roads Workforce Council Receives $14 Million from U.S. Department of Defense to Bolster Maritime Workforce
Funding to support regional workforce initiatives related to U.S. Navy’s Submarine Industrial Base NORFOLK, Va.–(BUSINESS WIRE)–The Hampton Roads Workforce... Read more.
Genentech’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
– Inavolisib in combination with palbociclib and fulvestrant more than doubled progression-free survival compared to palbociclib and fulvestrant alone – –... Read more.
Genentech’s Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment
– Phase III KATHERINE results reinforce Kadcyla as the standard of care for this population, with more than 82,000 people treated to date – – Long-term data... Read more.